{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:25:17Z","timestamp":1775913917502,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T00:00:00Z","timestamp":1325116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0029492","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T16:43:52Z","timestamp":1325177032000},"page":"e29492","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis"],"prefix":"10.1371","volume":"6","author":[{"given":"Isidoro","family":"Gonz\u00e1lez-\u00c1lvaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Alvaro-Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"D\u00edaz-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alberto","family":"Garc\u00eda-Vadillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Humbr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Pedro","family":"L\u00f3pez-Bote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva G.","family":"Tomero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther F.","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Sabando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Garc\u00eda-Vicu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,12,29]]},"reference":[{"key":"ref1","first-page":"25","article-title":"Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.","author":"CF Allaart","year":"2007","journal-title":"J Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/BOR.0b013e3282f5fcf6","article-title":"Biologic therapy for early rheumatoid arthritis: the latest evidence.","volume":"20","author":"H Castro-Rueda","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/ard.2008.100362","article-title":"Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.","volume":"68","author":"P Emery","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2009.123976","article-title":"Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.","volume":"69","author":"M Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.reuma.2009.10.006","article-title":"Actualizaci\u00f3n del Documento Consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre el uso de terapias biol\u00f3gicas en la artritis reumatoide.","volume":"6","author":"J Tornero Molina","year":"2010","journal-title":"Reumatol Clin"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/art.23439","article-title":"Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.","volume":"58","author":"JK de Vries-Bouwstra","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.berh.2008.08.001","article-title":"Predicting the development of RA in patients with early undifferentiated arthritis.","volume":"23","author":"K Raza","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.","volume":"57","author":"MA Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","article-title":"Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.","volume":"9","author":"P Szodoray","year":"2010","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1136\/ard.2009.119487","article-title":"Does gene expression analysis inform us in rheumatoid arthritis?","volume":"69","author":"T Haupl","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2418","article-title":"The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?","volume":"10","author":"JS Smolen","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1186\/ar1955","article-title":"Interleukin-15 and interferon-gamma participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production.","volume":"8","author":"I Gonzalez-Alvaro","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm0297-189","article-title":"Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis.","volume":"3","author":"IB McInnes","year":"1997","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.173.2.1463","article-title":"IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate.","volume":"173","author":"ME Miranda-Carus","year":"2004","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.","volume":"164","author":"M Ziolkowska","year":"2000","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/eji.200737229","article-title":"IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17.","volume":"37","author":"K Yoshihara","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2006.11.001","article-title":"Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K\/Akt and NF-kappaB.","volume":"108","author":"ML Cho","year":"2007","journal-title":"Immunol Lett"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1136\/ard.2008.096743","article-title":"Inhibition of TNF and IL-17 production by leflunomide involves the JAK\/STAT pathway.","volume":"68","author":"I Gonzalez-Alvaro","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1002\/art.21361","article-title":"The RANK\/RANKL\/osteoprotegerin system in rheumatoid arthritis: new insights from animal models.","volume":"52","author":"E Neumann","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.4049\/jimmunol.162.5.2754","article-title":"A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2.","volume":"162","author":"Y Ogata","year":"1999","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncprheum0036","article-title":"Mechanisms of Disease: the link between RANKL and arthritic bone disease.","volume":"1","author":"G Schett","year":"2005","journal-title":"Nat Clin Pract Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.21731","article-title":"Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.","volume":"54","author":"ME Miranda-Carus","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.","volume":"180","author":"WE Carson","year":"1994","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-5699(99)01581-9","article-title":"The emerging role of IL-15 in NK-cell development.","volume":"21","author":"CC Liu","year":"2000","journal-title":"Immunol Today"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/rheumatology\/ken257","article-title":"Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity.","volume":"47","author":"HP Carroll","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm0296-175","article-title":"The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis.","volume":"2","author":"IB McInnes","year":"1996","journal-title":"Nat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00296-001-0161-z","article-title":"CD69 expression on lymphocytes and interleukin-15 levels in synovial fluids from different inflammatory arthropathies.","volume":"21","author":"AM Ortiz","year":"2002","journal-title":"Rheumatol Int"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/(SICI)1096-9896(199704)181:4<444::AID-PATH778>3.0.CO;2-O","article-title":"Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis.","volume":"181","author":"EW Thurkow","year":"1997","journal-title":"J Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.21249","article-title":"Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study.","volume":"52","author":"B Baslund","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.160.11.5654","article-title":"Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen- induced immunopathology.","volume":"160","author":"H Ruchatz","year":"1998","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s002960100134","article-title":"Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis.","volume":"21","author":"OJ Cordero","year":"2001","journal-title":"Rheumatol Int"},{"key":"ref32","first-page":"639","article-title":"Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease.","volume":"21","author":"I Gonzalez-Alvaro","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"ref33","first-page":"2389","article-title":"Serum levels of interleukin 15 in patients with rheumatic diseases.","volume":"28","author":"J Suzuki","year":"2001","journal-title":"J Rheumatol"},{"key":"ref34","first-page":"186","article-title":"Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker.","volume":"21","author":"A Lamana","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"ref36","first-page":"2116","article-title":"Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency. Grupo para la Adaptacion del HAQ a la Poblacion Espanola.","volume":"20","author":"J Esteve-Vives","year":"1993","journal-title":"J Rheumatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.","volume":"38","author":"ML Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar2961","article-title":"A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.","volume":"12","author":"M Ibanez","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref39","article-title":"Generalized linear models and extensions","author":"J Hardin","year":"2007"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.0006-341X.2001.00529.x","article-title":"Model selection in estimating equations.","volume":"57","author":"W Pan","year":"2001","journal-title":"Biometrics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S1699-258X(06)73097-2","article-title":"III Actualizaci\u00f3n del Consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre terapia biol\u00f3gica en la artritis reumatoide.","volume":"2","author":"V Rodr\u00edguez-Valverde","year":"2006","journal-title":"Reumatol Clin"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0029492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T13:34:31Z","timestamp":1686576871000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0029492"}},"subtitle":[],"editor":[{"given":"Song Guo","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,29]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0029492","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13729956.15145056","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,29]]}}}